QUIDEL Corporation | News Releases

Skip to content

Investor Relations

Investor Relations

News Releases

$21.94 Change:

0.71

Receive E-mail Alerts

Webcast Image

Webcast
Quidel to Present at 2013 Bank of America Merrill Lynch Health Care Conference (Replay)
05/15/13 at 9:20 a.m. PT

Keyword Search

2013 | 2012 | 2011 | 2010 | 2009

Date	Title
05/08/13	Quidel to Present at Bank of America Merrill Lynch 2013 Health Care Conference
05/06/13	Quidel Completes Acquisition of BioHelix Corporation
04/23/13	Quidel Reports First Quarter 2013 Financial Results
04/10/13	Quidel to Hold First Quarter 2013 Financial Results Conference Call on April 23, 2013
03/25/13	Quidel Receives CE Mark for Its Molecular Diagnostic Test for Herpes Simplex Viruses (HSV 1, HSV 2) and Varicella-Zoster Virus (VZV)
03/18/13	Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and QuantStudio™ Dx and 7500 Fast Dx Real-Time PCR Instruments
03/12/13	Quidel Receives FDA Clearance for Its Molecular Diagnostic Test for Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV)
02/25/13	Quidel to Host 2013 Analyst and Investor Day in Boston
02/25/13	Quidel to Present at Cowen 33rd Annual Health Care Conference
02/12/13	Quidel Reports Fourth Quarter and Full Year 2012 Financial Results
01/31/13	Quidel to Hold Fourth Quarter and Full Year 2012 Financial Results Conference Call on February 12, 2013
01/04/13	Quidel Announces Preliminary Revenue for Fourth Quarter 2012
01/02/13	Quidel to Present at 31st Annual J.P. Morgan Healthcare Conference